Medicamen Biotech Chart
Medicamen Biotech Share Key Metrics
Volume
14103.00
Market Cap
376.30 CR
LTQ@LTP
10@277.45
ATP
272.41
Var Margin
100 %
Circuit Range
217.45-326.15
Delivery %
38.95 %
Value
38.42 L
ASM/GSM
No
Market Lot
1
Summary
Medicamen Biotech Fundamentals
View MoreP/E Ratio
40.32
P/B Ratio
1.41
Div. Yield
0.36
Sector P/E
71.32
Sector P/B
3.47
Sec. Div. Yield
0.56
Medicamen Biotech Resistance and Support
Pivot 277.98
Resistance
First Resistance
287.86
Second Resistance
303.93
Third Resistance
313.81
Support
First Support
261.91
Second Support
252.03
Third Support
235.96
Medicamen Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-13 | Quarterly Results |
Medicamen Biotech News
About Medicamen Biotech AboutThe
NSE : 6278
BSE : 531146
ISIN : INE646B01010
MBL was incorporated as a public limited company under the Companies Act 1956 on December 22 1993. The certificate of commencement of business was obtained on January 31 1994. The company has jointly been promoted by Mr.V.Kumar Mr.Bal Kishan Gupta Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst Cadila Hindustan Ciba Purepharma Oboi Labs etc. and exporting to countries like Germany Russia Holland CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.MBL has obtained permission for production of tablets capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited New Delhi and Pure Pharma Private Limited Indore respectively.
Medicamen Biotech Management
| Name | Position |
|---|---|
| Rahul Bishnoi | Chairman |
| Vimal Kumar Shrawat | Non Independent & Non Executive Director |
Medicamen Biotech FAQs
